UniProt ID | CCNE1_HUMAN | |
---|---|---|
UniProt AC | P24864 | |
Protein Name | G1/S-specific cyclin-E1 | |
Gene Name | CCNE1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 410 | |
Subcellular Localization | Nucleus . | |
Protein Description | Essential for the control of the cell cycle at the G1/S (start) transition.. | |
Protein Sequence | MPRERRERDAKERDTMKEDGGAEFSARSRKRKANVTVFLQDPDEEMAKIDRTARDQCGSQPWDNNAVCADPCSLIPTPDKEDDDRVYPNSTCKPRIIAPSRGSPLPVLSWANREEVWKIMLNKEKTYLRDQHFLEQHPLLQPKMRAILLDWLMEVCEVYKLHRETFYLAQDFFDRYMATQENVVKTLLQLIGISSLFIAAKLEEIYPPKLHQFAYVTDGACSGDEILTMELMIMKALKWRLSPLTIVSWLNVYMQVAYLNDLHEVLLPQYPQQIFIQIAELLDLCVLDVDCLEFPYGILAASALYHFSSSELMQKVSGYQWCDIENCVKWMVPFAMVIRETGSSKLKHFRGVADEDAHNIQTHRDSLDLLDKARAKKAMLSEQNRASPLPSGLLTPPQSGKKQSSGPEMA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
59 | Phosphorylation | TARDQCGSQPWDNNA HHHHHHCCCCCCCCC | 40.47 | 17525332 | |
73 | Phosphorylation | AVCADPCSLIPTPDK CCCCCCCCCCCCCCC | 34.42 | 14536078 | |
77 | Phosphorylation | DPCSLIPTPDKEDDD CCCCCCCCCCCCCCC | 36.81 | 15364936 | |
87 | Phosphorylation | KEDDDRVYPNSTCKP CCCCCCCCCCCCCCC | 9.52 | 24719451 | |
90 | Phosphorylation | DDRVYPNSTCKPRII CCCCCCCCCCCCEEE | 30.58 | 22817900 | |
91 | Phosphorylation | DRVYPNSTCKPRIIA CCCCCCCCCCCEEEC | 31.05 | 28634298 | |
100 | Phosphorylation | KPRIIAPSRGSPLPV CCEEECCCCCCCCCC | 40.01 | 30266825 | |
103 | Phosphorylation | IIAPSRGSPLPVLSW EECCCCCCCCCCCEE | 23.35 | 19664994 | |
109 | Phosphorylation | GSPLPVLSWANREEV CCCCCCCEECCHHHH | 25.11 | 28152594 | |
366 | Phosphorylation | NIQTHRDSLDLLDKA HHHHCHHHHHHHHHH | 24.60 | 18691976 | |
381 | Phosphorylation | RAKKAMLSEQNRASP HHHHHHHCCCCCCCC | 24.85 | 23898821 | |
387 | Phosphorylation | LSEQNRASPLPSGLL HCCCCCCCCCCCCCC | 24.59 | 30266825 | |
391 | Phosphorylation | NRASPLPSGLLTPPQ CCCCCCCCCCCCCCC | 50.16 | 30266825 | |
395 | Phosphorylation | PLPSGLLTPPQSGKK CCCCCCCCCCCCCCC | 37.66 | 19276368 | |
399 | Phosphorylation | GLLTPPQSGKKQSSG CCCCCCCCCCCCCCC | 59.35 | 17192257 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
73 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
77 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
387 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
395 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
395 | T | Phosphorylation | Kinase | GSK3A | P49840 | PSP |
395 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
395 | T | Phosphorylation | Kinase | GSK-FAMILY | - | GPS |
395 | T | Phosphorylation | Kinase | GSK3 | - | Uniprot |
399 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
399 | S | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:18851830 |
- | K | Ubiquitination | E3 ubiquitin ligase | UHRF2 | Q96PU4 | PMID:21952639 |
- | K | Ubiquitination | E3 ubiquitin ligase | RHOBTB3 | O94955 | PMID:24145166 |
- | K | Ubiquitination | E3 ubiquitin ligase | SKP2 | Q13309 | PMID:10790373 |
- | K | Ubiquitination | E3 ubiquitin ligase | PRKN | O60260 | PMID:12628165 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW7 | Q969H0 | PMID:11533444 |
- | K | Ubiquitination | E3 ubiquitin ligase | MDM2 | Q00987 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW2 | Q9UKT8 | PMID:17298674 |
- | K | Ubiquitination | E3 ubiquitin ligase | SPOP | O43791 | PMID:30237511 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCNE1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100; SER-103; SER-381;SER-387 AND THR-395, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-103; SER-387 ANDTHR-395, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND MASSSPECTROMETRY. | |
"Multisite phosphorylation by Cdk2 and GSK3 controls cyclin Edegradation."; Welcker M., Singer J., Loeb K.R., Grim J., Bloecher A.,Gurien-West M., Clurman B.E., Roberts J.M.; Mol. Cell 12:381-392(2003). Cited for: PHOSPHORYLATION AT THR-77; SER-387; THR-395 AND SER-399. | |
"Activation of cyclin E/CDK2 is coupled to site-specificautophosphorylation and ubiquitin-dependent degradation of cyclin E."; Won K.A., Reed S.I.; EMBO J. 15:4182-4193(1996). Cited for: PHOSPHORYLATION AT THR-395. |